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Abstract
Background: Age-related macular degeneration (AMD) is the leading cause of vision loss in elderly people over
60. The pathogenesis is still unclear. It has been suggested that lysosomal stress may lead to drusen formation, a
biomarker of AMD. In this study, ARPE-19 cells were treated with chloroquine to inhibit lysosomal function.
Results: Chloroquine-treated ARPE-19 cells demonstrate a marked increase in vacuolation and dense intracellular
debris. These are identified as chloroquine-dilated lysosomes and lipid bodies with LAMP-2 and LipidTOX co-
localization, respectively. Dilation is an indicator of lysosomal dysfunction. Chloroquine disrupts uptake of
exogenously applied rhodamine-labeled dextran by these cells. This suggests a disruption in the phagocytic
pathway. The increase in LAMP protein levels, as assessed by Western blots, suggests the possible involvement in
autophagy. Oxidative stress with H2O2 does not induce vacuolation or lipid accumulation.
Conclusion: These findings suggest a possible role for lysosomes in AMD. Chloroquine treatment of RPE cells may
provide insights into the cellular mechanisms underlying AMD.
Background
Age-Related Macular Degeneration (AMD) is the leading
cause of progressive central vision loss in elderly people
over the age of 60 [1-3]. The clinical hallmarks of “dry”
AMD, which accounts for 85-90% of AMD patients, is
the appearance of yellow pigments known as drusen and
marked photoreceptor death within the macula [1,4].
While it has been established that smoking, light expo-
sure and genetics are risk factors for AMD, its cellular-
molecular pathogenesis remains unclear [4].
Retinal pigment epithelium (RPE) metabolism is an
important factor in drusen buildup along the Bruch’s
membrane, located strategically between the choroid
and RPE [4]. The RPE, a highly specialized monolayer
epithelium that forms the outermost layer of the retina,
is among the most active phagocytic systems in the
body [5,6]. On a daily basis, the outer segment tips of
photoreceptors are phagocytosed into the RPE, and
digested in phago-lysosomes within the RPE [7]. Autop-
hagy also contributes to the heavy load of material the
RPE digests [8]. In theory, lysosomal overload may thus
lead to a buildup of biological “waste products”,r e d u -
cing RPE efficiency and contributing to extracellular
protein-lipid deposits along Bruch’s membrane [4,8-10].
Lysosomal overload and dysfunction in RPE is suspected
to be a critical and early cause of AMD [4,11]. It is well
established that lipofuscin, a pigmented aggregate of pro-
teins and lipids, a primary component of drusen, and an
AMD biomarker, is sequestered by lysosomes in RPE
[12,13]. At critical concentrations, N-retinylidene-N-
retinylethanolamine (A2-E), a fluorescent pigment of lipo-
fuscin, inhibits lysosomal ATPase proton pumps, inhibits
critical enzymes and causes lysosomal compartment leak-
age into RPE cytoplasm [4,14,15]. Recently, it has been
shown that the variant B mutation in cystatin C, a widely
expressed lysosomal protease inhibitor, inhibits proteolytic
regulator secretion, mistargets signaling, causes inap-
propriate cell protein retention and is associated with
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fied by lipid peroxidation similar to those found in lipofus-
cin have been shown to reduce proteolytic activity of
lysosomes of RPE cells [17]. Finally, studies have begun to
uncover a link between retinal degeneration and Nie-
mann-Pick type C, a known lysosomal storage disease. A
recent study observed that mice with mutations in the
Npc1 and Npc2 gene, which transcribe proteins that med-
iate the exit of lipoproteins from lysosomes, demonstrate
striking retinal degeneration, upregulation of autophagy
and marked lipofuscin accumulation within the RPE [18].
These aforementioned studies suggest that abnormalities
in the structural integrity and enzymatic activity of the
lysosomes of RPE cells may play a role in the pathogenesis
of AMD.
In this study, we investigate the possible role of lyso-
somes in AMD by treating in vitro human adult retinal
pigmented epithelium-19 (ARPE-19) cells, which have
previously been used as a model for the study of the
etiology and development of AMD [19,20], with chloro-
quine, a known lysosomotropic agent. The effects of
chloroquine as a retinopathic agent, as observed by lyso-
somal dysfunction and RPE degradation, have been
demonstrated in various animal models [21-24]. We use
the ability of chloroquine to increase pH [25] to both
understand the general effects of chloroquine on ARPE-
19, and as a model for lysosomal inhibition. The results
demonstrate that chloroquine induces vacuole forma-
tion, cell death, cytosolic lipid buildup and decreased
exogenous dextran uptake in ARPE-19.
Results
ARPE-19 Lysosomal Inhibition with Chloroquine
Treatment
Chloroquine is a known lysosomotropic agent that
increases lysosomal pH by accumulating within lyso-
somes as a deprotonated weak base. To study the effects
of lysosomal dysfunction in ARPE-19, it was necessary
to establish an in vitro model utilizing chloroquine. We
determined the concentration of chloroquine that sub-
stantially changed lysosomal activity, but did not result
in cell necrosis.
To find an optimal concentration of chloroquine that
did not affect ARPE-19 cell viability, we utilized both
DAPI nuclei staining and the MTT assay (Figure 1). For
DAPI cell quantification, the nuclei of ten random areas
of the coverslip were counted. The results (not shown)
of these counts were averaged, expressed as the percen-
tage of the control, and analyzed by student t-test and
one-way ANOVA with a TI-89 Texas Instruments
graphing calculator. The DAPI analysis showed cell via-
bility was time and dosage dependent, with concentra-
tions of 10-20 μg/ml at 24 hour incubation periods not
significantly (p < 0.05, n = 6) affected.
The MTT assay, which evaluated cell proliferation by
measuring metabolic activity, showed similar results.
Figure 1 demonstrates that cell viability and metabolism
is relatively unaffected from 10-30 μg/ml and is dosage
dependent. Student t-test shows no significant difference
from 10-20 μg/ml (p < 0.05, n = 6) with significant dif-
ference in cell viability between 10 and 40 μg/ml (p =
0.033, <0.05, n = 6).
Chloroquine Induces Cytosolic Vacuolation and Dense
Body Formation
Having determined that low concentrations (10-20 μg/ml)
at 24-hour incubation did not significantly reduce viability,
we evaluated the cytoplasmic cellular changes in ARPE-19
with phase contrast microscopy. Figure 2 shows the pro-
gression of cytoplasmic changes of ARPE-19 treated with
chloroquine under phase contrast microscopy. We found
that 10-20 μg/ml of chloroquine induced marked vacuola-
tion within the cytoplasm of ARPE-19, as can be seen in
Figure 3. In addition to increased vacuole size and disper-
sion, we note the appearance of dense, black, circular for-
mations interspersed throughout the cytoplasm and
around the large vacuoles. Vacuole and dense body size
increased with chloroquine dosage. In a parallel study per-
formed on NIH 3T3 cells, we noted the dilation of lyso-
somes at similar concentrations of chloroquine treatment
(Figure 4). However, there was no concurrent develop-
ment of the dense, black formations.
Lamp-2 Co-localizes with Dilated Vacuoles, LipidTOX Co-
localizes with Dense Formations
To determine if the abnormal vacuoles were dilated
lysosomes, as documented in a previous study using calf
RPE [26], and if the dense bodies contained lipid,
ARPE-19 cells were doubled stained with LAMP-2 anti-
body and LipidTOX neutral lipid. Inhibition of the
Figure 1 Cell Viability Assay. MTT assay shows chloroquine
toxicity is both time and dose dependent. Chloroquine
concentrations of 10-30 μg/ml (p < 0.05) do not significantly affect
cell viability.
Chen et al. Cell & Bioscience 2011, 1:10
http://www.cellandbioscience.com/content/1/1/10
Page 2 of 10Figure 2 Cytoplasmic Changes with Chloroquine in ARPE-19. Phase contrast microscopy of ARPE-19 with 0 (A), 10 (B), 20 (C), 40 (D), 80 (E)
μg/ml chloroquine. Chloroquine treatment causes membrane-enclosed vacuoles (red arrows) and membranous dense bodies (blue arrows).
ARPE treated with high chloroquine dosage show signs of cell death. Bar size = 25 microns.
Figure 3 Co-localization of LAMP-2 and LipidTOX. (A-D) Control ARPE-19. (E-H) 20 μg/ml chloroquine-treated ARPE-19. Control phase contrast
(A) shows no vacuolation and LAMP-2 (B, green), and LipidTOX(C, red) staining is observed throughout cell. D is fluorescent overlay.
Chloroquine-treated cell in phase contrast (E) shows intense vacuolation (white arrows). These vacuoles co-localize with LAMP-2 staining (F,
corresponding white arrows). Chloroquine treatment also induces dense body formation (E, yellow arrows). Dense formations co-localize with
neutral lipid (G, corresponding yellow arrows). Overlay (H) shows no overlap between lipids and vacuoles. Bar size = 25 microns.
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mucopolysaccharides is characteristic of chloroquine-
dilated lysosomes [25]. Moreover, lipid co-localization
would suggest a form of intracellular “biological debris”
accumulation within the cell in response to lysosomal
enzymatic inhibition.
LAMP-2 antibody staining of chloroquine-treated cells
was used to co-localize dilated vacuoles with lysosomes
and phago-lysosomal complexes. As shown in Figure 3
LAMP-2 antibody staining co-localizes with membranes
of dilated vacuoles. We did not observe noticeable dif-
ference in the strength of antibody staining between
control and chloroquine-treated cells. LipidTOX stain-
ing localized in the perinuclear and peripheral area of
the cell. Figure 3 shows co-localization of dense bodies
with LipidTOX, especially in the periphery of cells. As a
control for non-specific staining, cells washed with Tri-
ton × showed no LipidTOX staining. Chloroquine
caused no morphological changes in the Golgi apparatus
or mitochondria (Figure 5). Figure 5 shows no co-locali-
zation, and there was no marked decrease in mitochon-
drial staining between control and 10-20 μg/ml
chloroquine treatment. It appears that co-localized lipids
may represent intracellular debris, the consequence of
the dysfunctional lysosomes.
ARPE-19 Phagocytic Pathway is Disrupted by Chloroquine
We use Western blotting of LAMP-1 and 2 (Figure 6A)
and exogenous rhodamine-labeled dextran (Figure 6B)
to observe disruption of chloroquine-treated autophagic
and phagocytic pathways, respectively. If phagocytic
function is normal, LAMP-1 and LAMP-2 protein levels
should remain relatively the same despite chloroquine
treatment. Quantitative examination of the Western
blots was performed by densitometry [27] (ImageJ Soft-
ware, available at http://rsb.info.nih.gov/ij/). Western
blots in Figure 6 show marked increase of LAMP-1 in
chloroquine-treated cells, especially at 10 μg/ml. LAMP-
2 shows a similar, but less drastic, upregulation trend.
Exogenous rhodamine-labeled dextran was applied to
the chloroquine-treated cells. We observe a striking
decrease in intracellular dextran in chloroquine-treated
cells (Figure 7A). Dextran retention and uptake was
quantified by comparing relative maximas with ImageJ.
There is a significant decrease in intracellular dextran
between the control and 10 μg/ml treatment (Figure
7B). These findings suggest either increased exocytosis
or decreased phagocytic uptake.
H2O2 Oxidative Stress Test
Oxidative stress is one of the primary causes of AMD,
and is suspected as a primary catalyst of the disease
[28]. We investigated whether intracellular lipid accu-
mulation occurs to the same extent in ARPE cells trea-
ted with H2O2. No cytoplasmic dense aggregate
formation or lysosomal dilation occurred in H2O2-trea-
ted cells under phase contrast (Figure 8). There were no
striking differences in LAMP-2 and LipidTOX co-locali-
zation staining patterns in control and H2O2-treated
ARPE-19 cells. This suggests that aforementioned lipid
buildup in ARPE-19 observed with chloroquine treat-
ment is accelerated by induced alteration in lysosomal
function, and not secondary to oxidative stress.
Discussion
The molecular mechanisms by which drusen and AMD
develop are not clearly understood at this time. Drusen
has been postulated to be the combination of oxidative
stress, lipofuscin and POS overload lysosomal capacity
[4]. Here, we investigate the possible role of lysosomal
malfunction in AMD by examining the effects of chloro-
quine, a lysosomotropic agent, on ARPE-19 cells. Our
findings detail a time-dosage toxicity curve, marked
vacuolation in the cytoplasm, intracellular debris accu-
mulation, and altered phagocytic pathways in chloro-
quine treated ARPE-19.
Chloroquine proved to be an apt in vitro model for
observing the buildup of intracellular lipid in ARPE-19
cells. Chloroquine induced intense vacuolation of cells.
Figure 4 Co-localization of LAMP-1 in NIH/3T3.N I H / 3 T 3c e l l s
show a similar pattern of vacuole formation with treatment of
chloroquine. Phase contrast and corresponding LAMP-1 co-
localization of 25 μg/ml chloroquine-treated cells (C, D) show
vacuolation of LAMP-1, when compared with control (A, B). The
arrows in C and D note that the borders of the vacuoles
correspond with LAMP-1 protein. Bar size = 25 microns.
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similar conditions [29] and in bovine RPE under slightly
hypoxic conditions [23]. Vacuolation has been shown as
an indicator of altered acidification through a proton
“trapping” mechanism [25] and inhibition of key lysoso-
mal enzymes, including cathepsin D [30]. This is consis-
tent with in vivo findings that have demonstrated that
retinal aging has been associated with a decrease in lyso-
somal glycosidases and downregulation of cathepsin D
[31]. We further confirm the validity of dilation, and
thus induced inhibition of phago-lysosomes, by success-
ful co-localization with LAMP-2. Perhaps the most
striking finding was the co-localization of dense forma-
tion buildup with lipid staining. The lack of dense
bodies in 3T3 cells (Figure 4) suggests that this phe-
nomenon may be unique to cells of the retinal epithe-
lium. RPE cells by the nature of their function to
phagocytose POS are likely to be more dependent upon
lysosomal activity. Aberrations in this activity may lead
to the accumulation of the lipid bodies that ultimately
Figure 5 Chloroquine Effect on ARPE-19 Golgi and Mitochondria. (A-D) Mitochondria co-localization in (A-B) control and (C-D) 20 μg/ml-
treated ARPE-19. There is no difference in MitoTracker staining (red) intensity, shape or localization between control (B) and treatment (D).
Similarly, there were no noticeable changes in Golgi apparatus (E-H). Golgi co-localization of control (E-F) and 20 μg/ml chloroquine treatments.
Golgi is stained with Golgin-97 antibody staining (green). Bar size = 25 microns.
Figure 6 Phagocytic Activity and LAMP Protein. (A) Comparisons of LAMP-1 and LAMP-2 protein levels at different concentrations of
chloroquine. Protein levels measured in ARPE-19 by Western blot with beta-actin as loading control. Western shows marked qualitative increase
in LAMP 1-2 band size between control and 10 μg/ml chloroquine treatment, while loaded control is constant. (B) There is a significant increase
in LAMP-1 and 2 (p < 0.05) at 10 μg/ml with overall upregulation trend response to chloroquine treatment. Immunoblots (n = 6) were scanned,
and densitometry was performed on bands with ImageJ (NIH, Bethesda MD). Relative band density measurement was repeated several times to
ensure maximum and minimum values.
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to the well-established mitochondrial-axis theory [32],
we found that the accumulation of lipid, induced by
chloroquine, is not seen with an oxidative stress model
(Figure 8), which is possibly only a secondary factor.
Interestingly, increased LAMP-1 and 2 protein levels,
as well as decreased retention/uptake of exogenous dex-
tran, suggest that alterations in the phagocytic pathway
occur after lysosomal inhibition by chloroquine. Upregu-
lation of LAMP could indicate a number of intracellular
changes. It could be a reflection of a general increase in
lysosomal surface membrane size due to dilation, or an
overall increase in lysosomes. Furthermore, it may indi-
cate a compensatory upregulation in phagosome-lysoso-
mal fusion and movement [33]. It is possible that the
striking increase in LAMP-1 is an indication of the
onset of apoptosis, an observation noted in glioblastoma
cells in culture [34]. In contrast, chloroquine at low
dosages does not seem to induce increased autophagy,
as autophagic-associated vacuolation is correlated with
decreased LAMP-2 levels [35]. At the time of publica-
tion, we have initiated studies on siRNA knockdown of
LAMP protein to eludicate the mechanism of these pro-
tein changes in light of vacuolation.
Our exogenous dextran findings suggest either a lack
of intracellular retention or increased exocytosis due to
lysosomal inhibition. There is much debate on the
mechanisms that occurs in AMD. There is a belief that
the combination of oxidative stress and a decrease in
ATP drives the exocytosis of partially digested intracel-
lular proteins into the Bruch’s membrane [8]. However,
recent studies have investigated the role of ABCA4
transporter mutations in reducing movement of oxidized
lipids in Stargardt’s AMD [36]. Similarly, it has been
shown that oxidized lipid-proteins can block phagosome
formation, and thus deter internalization into RPE [37].
Another candidate for the cause of lysosomal dysfunc-
tion in cells is the degradation of the glycocalyx, which
protects the vital LAMP-2 membrane protein. While the
exact role of LAMP-2 is still unclear, it has been pro-
posed that it is responsible for equilibrating proton
levels in lysosomes. Moreover, recent studies suggest
LAMP-2 may be critical in communication between
phagosomes and lysosomes, and in receptor-targeting
for lysosome maturation [38-40]. We therefore postulate
a “LAMP-2/Lysosomal Inhibition” AMD biogenesis
Figure 7 Phagocytic Activity Measured by Dextran Uptake.( A -
B) Immunofluorescence of exogenous rhodamine-labeled dextran
(red) uptake with ImageJ markings (crosshairs) of counted dextran
maximas. 20 μg/ml chloroquine-treated cells at 24 hours (B) showed
striking decrease in fluorescent dextran uptake when compared to
control (A). (C) Quantization of dextran uptake between control and
chloroquine-treated ARPE-19. There is a significant (p < 0.05)
decrease in relative dextran uptake in individual sampled ARPE-19
cells between control and chloroquine-treated cells. Quantitation
was performed by using ImageJ, isolating cells of relative same size
(~20-25 microns), and then calculating florescent maximas
(tolerance = 20, based on control). Maximas were averaged and
standard t-test was performed (n = 10).
Figure 8 Oxidative Stress Test. (A) phase contrast, (B) LAMP-2 and
(C) LipidTOX staining of 10 mM hydrogen peroxide-treated ARPE-19.
(D) Overlay showing co-localization of neutral lipid and LAMP-2.
There are no differences in cell cytoplasm (vacuoles, lipids) in phase
or fluorescence between control (Fig 2 A-D) and hydrogen peroxide
treatment.
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inhibition begins with the modification or degradation
of the asparagine-linked glycocalyx of LAMP-2. Removal
of the glycocalyx results in rapid proteolysis of LAMP-2
[41]. The glycocalyx shield could be slowly modified or
degraded over time by the powerful proteases within the
lysosomal lumen, perhaps as a result of aging. Further
investigation will be required to understand the causes
of the breakdown of the glycocalyx. Nevertheless, after
LAMP-2 has been degraded, a pH shift occurs, dynein is
no longer able to pull mature phagosomes to lysosomes
or mistargeting of M6PR/Rab7 occurs [42]. Conse-
quently, the lysosome is incapable of degrading extra-
and intracellular material by phagolysosomal fusion.
This results in the accumulation of oxidized lipofuscin.
The combination of mitochondrial oxidative stress and
amassing of senile, inefficient mitochondria and iron in
lysosomes further expedites lipofuscin buildup.
In summary, these studies demonstrate two new find-
ings. First, we show the morphological changes in
ARPE-19 due to chloroquine. Also, we demonstrate that
lysosomal dysfunction leads to the accumulation of
lipids and their byproducts in ARPE-19 cells which may
simulate the situation in AMD. These findings seem to
be specific for this particular cell line, and we demon-
strate that despite lysosome dilation with chloroquine
treatment, this profuse lipid accumulation is not seen
with NIH 3T3 cells (Figure 4), neuroblastoma or glio-
blastoma cell lines that we have tested. This is perhaps
a reflection of the intense lysosomal/autophagocytic
activity of the RPE cells. These cells may be more sus-
ceptible to perturbations of the lysosomal degradation
systems and are thus a good model for studying poten-
tial mechanisms of AMD. There is a piqued interest in
the relationship between lysosomal inhibition and AMD
as seen in the recent literature on the correlation
between iron overload and reduced Cat-D activity [43],
the conversion of protease substrates to lysosomal
enzyme substrate inhibitors [44] and the possible usage
of toxins to elevate low pH in ARPE lysosomes [45].
Conclusions
These studies demonstrate the dose and time dependent
response of ARPE-19 to chloroquine. Moreover, we
have demonstrated that chloroquine induces intracellu-
lar vacuolation and lipid accumulation, and disrupts the
phagocytic pathway. Our observations appear to be
independent of oxidative stress. Lysosomal malfunction
Figure 9 Possible LAMP-2/Lysosomal Inhibition Model of Pathogenesis of AMD. An unknown cause results in loss of the protective
glycocalyx of LAMP-2. Proteolysis of LAMP-2 occurs. Loss of LAMP-2 results in either 1) A pH shift and loss of acidity of lysosome, 2) dynein no
longer moving late phagosome to microtubule sorting center near Golgi for fusion with lysosome or 3) perturbation of M6PR/Rab recycling such
that M6PR/Rab7 does not tag late endosomes. The loss of functionality of M6PR/Rab7 results in a lack of phagosome lysosome-fusion. Any of
these results in loss of the lysosome’s ability to degrade intra- and extracellular material. Subsequently, undegraded material is oxidized, turning
to lipofuscin. Ultimately, the combination of oxidative stress, Fe+ accumulation, senile mitochondria and decrease in ATP results in inefficient
turnover of organelles and increased inhibition of lysosomes. RPE death triggers photoreceptor and macula death.
Chen et al. Cell & Bioscience 2011, 1:10
http://www.cellandbioscience.com/content/1/1/10
Page 7 of 10m a yt h u sh a v eap i v o t a lr o l ei nt h ep a t h o g e n e s i so f
AMD.
Methods
Cell Culture Growth Technique
Human ARPE-19 tissue culture cells were obtained from
American Tissue Culture Center, Rockville, MD (ATCC,
CRL-2502). Cells were grown in Ham’sF 1 2M e d i a :
DMEM (1:1) (ATCC, 30-2006) with 10% fetal bovine
serum (FBS) (ATCC, 30-2030) as monolayers at 37°C with
5% CO2 in 100 × 20 mm round culture dishes (Falcon, 35-
3003). NIH/3T3 cells, embryonic mouse fibroblast cells,
were also obtained from ATCC (CRL-1658) and grown in
DMEM (ATCC, 30-2002) with 10% calf bovine serum
(ATCC, 30-2030) at the same conditions as ARPE cells.
The cells were propagated by splitting at a ratio of 1:5
with a trypsin-EDTA solution. Studies were done on both
ARPE-19 and 3T3 cells during passages 5-15.
Chloroquine
Chloroquine was obtained from Sigma (C6628, St.
Louis, MO). Chloroquine stock solutions were made at
10 mg/ml in double deionized water, and sterilized by
filtration with an Acrodisc syringe filter with a 0.2 μm
Tuffryn membrane (Pall Life Sciences, New York). Ali-
quots of the sterile stock solutions were stored at -20°C
until use. The appropriate amounts of stock solution
were added to the media to achieve the desired concen-
tration. To test the effect of the carrier, equivalent
volumes of sterile water were also added to a set of
ARPE-19 cells.
Response of ARPE-19 Cells to Chloroquine
Approximately 50,000 cells were seeded into each well
of a 12-well plate (Falcon 35-3043) and grown to 50%
confluency on sterile glass coverslips. These were incu-
bated with chloroquine at concentrations of 0, 10, 20,
40, 80 and 100 μg/ml for 24 hours. In a separate set of
experiments, cells were incubated at 0, 40 and 80 μg/ml
for 2 hours and 6 hours. To demonstrate that the carrier
did not affect the ARPE-19 cells, sterile water, in a
quantity equivalent to that of the carrier, was added to a
triplicate set of RPE cells. Each point on the graph in
Figure 1 represents seven independent experiments. The
loss of cells after the different chloroquine treatments
was determined by counting the cells on the coverslip.
To visualize the cells, 4’-6-Diamidino-2-phenylindol
(DAPI) was used to stain the cell nuclei. After the desig-
nated treatment, coverslips were fixed in situ in 3.7%
paraformaldehyde. Coverslips were washed three times
with 1X phosphate buffered saline (PBS), and then once
with PBS containing 1 μg/ml DAPI and 0.1% saponin.
The stained cells were visualized through a DAPI filter
with a 20× panfluorochrome objective with a BX50
Olympus microscope. Ten random fields from each cov-
erslip were photographed and counted.
Cell Proliferation Assay
An MTT assay kit was obtained from Roche (11465
007001). Approximately 5,000 cells were seeded into each
well of a 96-well plate, and were grown to ~50% con-
fluency. Chloroquine treatments of 20, 30, 40, 50, 60, and
80 μg/ml were administered in 100 μl of media/well, and
cells were incubated for 24 hours at 37°C. After this first
incubation period, 10 μl of MTT labeling reagent was
added to each well, bringing the final concentration of
MTT labeling reagent to 10 mg/ml. The cells were incu-
bated for 4 hours. At this point, 100 μl of the solubilization
solution was added to each well, and the plate was incu-
bated overnight. After this last incubation period, the spec-
trophotometric absorbance of the samples was measured
using an ELISA reader.
LAMP-2 and Cy2 Secondary Antibodies
Anti-human LAMP-2 monoclonal antibody (anti-mouse
IgG1) was obtained as stock hybridoma tissue superna-
tants from The Developmental Studies Hybridoma Bank
(University of Iowa) and diluted (1:50) in a 0.1% Bovine
Albumen Serum (BSA)/0.1% saponin/PBS solution. The
secondary goat-anti-mouse cy2 or rhodamine antibody
(Kirkegaard and Perry, Gaithersburg, MD) was diluted
(1:60) with 0.1% BSA/0.1% saponin/PBS.
LAMP-2 Immunofluorescent Staining
RPE and 3T3 cells were stained for LAMP-2 as pre-
viously described [46].
Neutral Lipid Stain
Stock HCS LipidTOX Red Neutral Lipid Stain (Invitrogen,
H34475) was diluted 1:4000 in PBS. Coverslips with Lipid-
TOX were incubated for 15-20 minutes at room tempera-
ture. LipidTOX was then removed and cells were washed
once with 1X PBS. To test LipidTOX specificity, cells were
washed with 0.1% Triton X-100 in PBS prior to staining
with LipidTOX. Triton X-100-washed cells functioned as
a control, demonstrating no staining with the LipidTOX.
Epifluorescence and Phase Contrast Microscopy
An Olympus BX50 microscope with phase contrast and
epifluorescent capabilities, attached to an Olympus
DP11 or DP20 digital camera, was used for DAPI (20×)
images. This was also used for phase contrast and fluor-
escent-labeled studies (60×, oil immersion).
Mitochondria Staining
MitoTracker CMX Ros Red (Invitrogen, M7512) was
dissolved in dimethyl sulphoxide (DMSO [Sigma]) to
achieve a final stock concentration of 1 mM. Cells were
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concentrations of 10, 20 and 40μg/ml. To stain the
mitochondria, cells were incubated for 15 minutes at 37°
C in fresh media with MitoTracker at a concentration
of 300 nM, and then fixed with 3.7% paraformaldehyde.
Cells were washed in 1× PBS three times, viewed with
epifluorescence, and photographed as previously
described.
Golgi Stain
Anti-Golgin 97 mouse IgG1 (Invitrogen, 49363A) was
dissolved in 1× PBS to create a final concentration of
200 μg/ml. The cells were incubated with anti-golgin 97
and the LAMP-2 antibodies, both diluted 1:50 in 0.1%
BSA/0.1% saponin/PBS. The Golgi stain was visualized
with rhodamine-labeled goat anti-mouse secondary anti-
body (Kirkegaard and Perry, Gaithersburg, MD).
Western Blotting
Western blots were performed with modifications for
LAMP-2 [39]. LAMP-2 was administered at a concen-
tration of 1:2000, followed by incubation with goat anti-
mouse peroxidase-conjugated secondary antibodies
(BioRad, 1:3000). Antigen-antibody complexes were
detected using chemiluminescence reagent kit (Perkin-
Elmer ECL). The blots were stripped and then probed
with actin to function as a control.
H202 Oxidative Stress Study
A stock concentration of 3% hydrogen peroxide (H2O2,
0.88 M) was diluted in the growth media to attain final
concentrations ranging from 0.2 to 10 mM [28]. The
treated cells were incubated for 24 hours. Following
incubation, cells were visualized by phase contrast
microscopy and stained with LAMP-2, LipidTOX, Anti-
Golgin 97, and MitoTracker.
Dextran Uptake Studies
Rhodamine-conjugated dextran, avg. 10,000 MW, was
obtained from Invitrogen. A stock solution of dextran
diluted in sterile, deionized water was prepared. Cells were
grown in different concentrations of chloroquine on
round glass coverslips in 24-well plates for 24 hours. After
24 hours of incubation, the media was removed and
replaced with new media containing the same amount of
chloroquine, as well as an additional 0.05 mg/ml of rhoda-
mine-conjugated dextran. At this point, the cells were
incubated for 6 hours, and then fixed in 3.7% paraformal-
dehyde in PBS. Cells were mounted in a 10% glycerol-PBS
solution, visualized, and photographed immediately.
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